endometrial cancerrecurrenceroutine follow‐upsymptomDuring routine follow-up for postoperative endometrial cancer, we have encountered patients with and without symptoms at recurrence. In this study, we investigated whether or not there is a difference in the prognosis between patients with and without ...
Endometrial cancer (EC) is one of the most common malignancies in the female genital system, characterized by high mortality and recurrence rates. This study attempted to screen key genes and potential prognostic biomarkers for EC using bioinformatics analysis. Twenty锕昬ven normal endometrial tissues ...
Endometrial cancer is highly malignant and has a poor prognosis in the advanced stage, thus, prediction of its prognosis is important. DNA methylation has rapidly gained clinical attention as a biomarker for diagnostic, prognostic and predictive purposes in various cancers. In present study, differenti...
Risk and prognosis of endometrial cancer after tamoxifen for breastcancer.SummaryBackground: Tamoxifen increases the risk of endometrial cancer. However, few studies have produced reliable risk estimates by duration, dose, and recency of use, or addressed the prognosis of endometrial cancers in ...
A wide variety of prognostic variables for recurrence and death from endometrial cancer exist. It can be difficult to isolate the importance of any single factor and certainly the presence of multiple poor prognostic variables portends a worse outcome. For that reason, nomograms have been developed...
A newly discovered endometrial cancer biomarker and diagnostic method will enable detection of the tumor type that is likely to spread and recur so that clinicians can initiate treatment early and stop the cancer from attacking other parts of the body.
Purpose: Endometrial cancer arising in adenomyosis (EC-AIA) is frequently detected accidentally following a general hysterectomy for adenomyosis. Whether supplemental lymphadenectomy in patients with EC-AIA can improve the survival outcome remains inconclusive. Herein, the authors summarized the data of ...
This study investigated whether the inflammation-based Glasgow prognostic score (GPS) predicted the prognosis of patients with endometrial cancer (EC) in terms of progression-free survival (PFS) and overall survival (OS). Study design Pretreatment GPS was examined to determine the correlations with ...
analyzed, our methodology produced predictive models for four additional tumor types: breast cancer (BRCA), cervical squamous cell carcinoma (CESC), sarcoma (SARC), and uterine corpus endometrial carcinoma (UCEC), as well as quite a few predictive models for additional cancers and outcomes that ...
Simple Summary: Endometrial cancer has become increasingly common owing to the recent westernization of diet and lifestyle, with 1.7% of cancer patients dying annually. Furthermore, the 5-year endometrial cancer survival rate is barely 15%. Nectin-4 has emerged as a possible biomarker and therapeu...